DK1246824T3 - Diazepine carboxamide derivatives, their preparation, their use as drugs, pharmaceuticals and their use - Google Patents

Diazepine carboxamide derivatives, their preparation, their use as drugs, pharmaceuticals and their use

Info

Publication number
DK1246824T3
DK1246824T3 DK00990087T DK00990087T DK1246824T3 DK 1246824 T3 DK1246824 T3 DK 1246824T3 DK 00990087 T DK00990087 T DK 00990087T DK 00990087 T DK00990087 T DK 00990087T DK 1246824 T3 DK1246824 T3 DK 1246824T3
Authority
DK
Denmark
Prior art keywords
pharmaceuticals
drugs
preparation
products
carboxamide derivatives
Prior art date
Application number
DK00990087T
Other languages
Danish (da)
Inventor
Neerja Bhatnagar
Jacques Mauger
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9553901&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1246824(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of DK1246824T3 publication Critical patent/DK1246824T3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

The invention concerns products of formula (I) wherein: R1 represents in particular -C(O) -R5, -SO2 -R5 or -C(O) -NR6R5, R2 and R7 are such that either R7 represents a hydrogen atom and R2 is such that the group (a) represents the radical of a natural or non-natural amino acid, or R2 and R7 form together a cycle with the nitrogen and carbon atom whereto they are bound, R3 represents in particular the radical -CH=N2 or -CH2-L-R4, R4 represents in particular a linear or branched alkyl radical, and their additive salts with mineral or organic acids or with mineral or organic bases of said products of formula (I). The invention also concerns the method for preparing said products and their use as medicines.
DK00990087T 1999-12-28 2000-12-21 Diazepine carboxamide derivatives, their preparation, their use as drugs, pharmaceuticals and their use DK1246824T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9916567A FR2802927B1 (en) 1999-12-28 1999-12-28 NOVEL DIAZEPINE CARBOXAMIDE DERIVATIVES, THEIR PREPARATION PROCESS, THEIR USE AS MEDICAMENTS, PHARMACEUTICAL COMPOSITIONS AND THEIR NEW USE
PCT/FR2000/003622 WO2001047930A1 (en) 1999-12-28 2000-12-21 Carboxamide diazepin derivatives, preparation method, use as medicines, pharmaceutical compositions and use thereof

Publications (1)

Publication Number Publication Date
DK1246824T3 true DK1246824T3 (en) 2004-10-18

Family

ID=9553901

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00990087T DK1246824T3 (en) 1999-12-28 2000-12-21 Diazepine carboxamide derivatives, their preparation, their use as drugs, pharmaceuticals and their use

Country Status (26)

Country Link
EP (1) EP1246824B1 (en)
JP (1) JP2003519152A (en)
KR (1) KR20020062772A (en)
AT (1) ATE268775T1 (en)
AU (1) AU780522B2 (en)
BR (1) BR0016845A (en)
CA (1) CA2395275A1 (en)
DE (1) DE60011473T2 (en)
DK (1) DK1246824T3 (en)
EA (1) EA005288B1 (en)
EE (1) EE200200362A (en)
ES (1) ES2218275T3 (en)
FR (1) FR2802927B1 (en)
HR (1) HRP20020558A2 (en)
HU (1) HUP0203921A3 (en)
IL (1) IL150419A0 (en)
MX (1) MXPA02006413A (en)
NO (1) NO20023107L (en)
NZ (1) NZ519884A (en)
PL (1) PL355950A1 (en)
PT (1) PT1246824E (en)
SI (1) SI1246824T1 (en)
SK (1) SK9092002A3 (en)
WO (1) WO2001047930A1 (en)
YU (1) YU47502A (en)
ZA (1) ZA200205221B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20220115062A (en) 2021-02-09 2022-08-17 (주)오스티오뉴로젠 Pharmaceutical Composition For Treating and Preventing Osteoporosis Comprising Compounds of Chromone Scaffold

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6204261B1 (en) * 1995-12-20 2001-03-20 Vertex Pharmaceuticals Incorporated Inhibitors of interleukin-1β Converting enzyme inhibitors
US5552400A (en) * 1994-06-08 1996-09-03 Sterling Winthrop Inc. Fused-bicyclic lactams as interleukin-1β converting enzyme inhibitors
US5847135A (en) * 1994-06-17 1998-12-08 Vertex Pharmaceuticals, Incorporated Inhibitors of interleukin-1β converting enzyme

Also Published As

Publication number Publication date
NO20023107L (en) 2002-08-27
FR2802927A1 (en) 2001-06-29
CA2395275A1 (en) 2001-07-05
ATE268775T1 (en) 2004-06-15
PT1246824E (en) 2004-10-29
NZ519884A (en) 2005-03-24
EP1246824B1 (en) 2004-06-09
MXPA02006413A (en) 2002-11-29
HUP0203921A2 (en) 2003-03-28
PL355950A1 (en) 2004-05-31
BR0016845A (en) 2002-10-15
DE60011473D1 (en) 2004-07-15
EP1246824A1 (en) 2002-10-09
IL150419A0 (en) 2002-12-01
WO2001047930A1 (en) 2001-07-05
YU47502A (en) 2005-03-15
SI1246824T1 (en) 2004-10-31
ES2218275T3 (en) 2004-11-16
SK9092002A3 (en) 2003-04-01
AU780522B2 (en) 2005-03-24
EA005288B1 (en) 2004-12-30
DE60011473T2 (en) 2005-06-30
AU2688801A (en) 2001-07-09
HUP0203921A3 (en) 2005-01-28
ZA200205221B (en) 2003-09-04
EA200200721A1 (en) 2002-12-26
FR2802927B1 (en) 2002-03-01
JP2003519152A (en) 2003-06-17
HRP20020558A2 (en) 2004-02-29
KR20020062772A (en) 2002-07-29
EE200200362A (en) 2003-08-15
NO20023107D0 (en) 2002-06-27

Similar Documents

Publication Publication Date Title
BR0114436A (en) Five element ring compound containing aliphatic nitrogen
ES2186253T3 (en) A METHOD FOR CONTROLLING THE RHEOLOGY OF A WATERY FLUID AND GELIFYING AGENT FOR SUCH CONTROL.
NZ324007A (en) Quinazoline derivatives susbtituted by a phenyl and medicaments
PA8539401A1 (en) QUINAZOLINAS AS INHIBITORS OF MMP-13
DE69628466D1 (en) Intermediate compounds for the preparation of new pyridonecarboxylic acid derivatives or their salts
BR0313160A (en) Compound, pharmaceutical composition, methods for treating a condition and a susceptible neoplasm in an animal in an animal, process for preparing a compound and use of a compound.
AR035548A1 (en) ORGANIC COMPOUNDS
BR0316375A (en) Diazinopyrimidines
EA200200510A1 (en) 4-CARBOXYAMINO-2-ETHYL-1,2,3,4-TETRAHYDROCHINOLINE IN A CRYSTAL FORM AS A CETR INHIBITOR
NO932120L (en) Biphenyl derivatives, drugs containing them, and methods for their preparation
BR0308162A (en) Thienopyridine indolyl urea derivatives useful as antiangiogenic agents and methods for their use
BR0309558A (en) Quinazoline derivatives and medicines
CR7249A (en) DERIVATIVES OF DIAMINE, PROCESS TO PRODUCE THE DERIVATIVES OF DIAMINE, AND FUNGUICIDES CONTAINING THE DERIVATIVES OF DIAMINE AS ACTIVE INGREDIENT
YU44202A (en) Quaternary salts of n-substituted cyclic or acyclic amines as pharmaceuticals
DE69916066D1 (en) NEW BENZOXAZOLES WITH PDE INHIBITING EFFECT
EA200101100A1 (en) NEW AROMATIC AMIDES SUBSTITUTED BY RIBOSE, METHOD OF THEIR RECEPTION AND THEIR APPLICATION AS A MEDICINE
DK1246824T3 (en) Diazepine carboxamide derivatives, their preparation, their use as drugs, pharmaceuticals and their use
WO2003022797A1 (en) Carba-sugar amine derivatives and treatments for disorder of glycolipid metabolism containing the same as the active ingredient
DK0968222T3 (en) Erythromycin derivatives, processes for their preparation and their use as drugs
RS50423B (en) Novel octahydro-6,10-dioxo-6h-pyridazino(1,2-a)diazepin -1-carboxylic acid derivatives, preparation method and use for preparing therapeutically active compounds
ATE244258T1 (en) HALO DERIVATIVES OF 9-DEOXO-9A-AZA-9A-HOMERYTHROMYCIN A
BR0108002A (en) Derivatives of heterocyclic amides
BR0015578A (en) Aryloxy propanolamines to improve livestock production
YU81502A (en) Cyclopostins, a method for their production and the use of the same
AR004220A1 (en) ALPHA-AMINO ACID MICROBICIDE AMIDES, PROCEDURE FOR THEIR PREPARATION, COMPOSITION AND METHOD TO CONTROL AND AVOID THE INFECTION OF PLANTS BY MICROORGANISMS